| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen.
|
Cancer Res
|
2000
|
1.88
|
|
2
|
Reduction in circulating levels of CD4-positive lymphocytes in acute pancreatitis: relationship to endotoxin, interleukin 6 and disease severity.
|
Br J Surg
|
1993
|
1.73
|
|
3
|
Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma.
|
Oncogene
|
2010
|
1.69
|
|
4
|
Effect of cell density on the expression of adhesion molecules and modulation by cytokines.
|
Cytometry
|
1995
|
1.39
|
|
5
|
Adhesion molecules in inflammatory bowel disease.
|
Gut
|
1995
|
1.36
|
|
6
|
Molecular evidence for a single clonal origin in biphenotypic concomitant chronic lymphocytic leukemia and multiple myeloma.
|
Blood
|
1989
|
1.28
|
|
7
|
miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis.
|
Br J Cancer
|
2013
|
1.21
|
|
8
|
Improving the accuracy of pre-operative survival prediction in renal cell carcinoma with C-reactive protein.
|
Br J Cancer
|
2010
|
1.18
|
|
9
|
Effects of interleukin 6 administration on platelets and haemopoietic progenitor cells in peripheral blood.
|
Cytokine
|
1996
|
1.02
|
|
10
|
Serum concentrations of soluble adhesion molecules in patients with colorectal cancer.
|
Br J Cancer
|
1998
|
1.01
|
|
11
|
Laser capture microdissection and proteomics: possibilities and limitation.
|
Proteomics
|
2001
|
0.98
|
|
12
|
A phase II study of interferon-alpha, interleukin-2 and 5-fluorouracil in advanced renal carcinoma: clinical data and laboratory evidence of protease activation.
|
Br J Urol
|
1996
|
0.96
|
|
13
|
Circulating soluble adhesion molecules E-cadherin, E-selectin, intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in patients with gastric cancer.
|
Br J Cancer
|
1997
|
0.96
|
|
14
|
Expression of interleukin-6 by intestinal enterocytes.
|
J Clin Pathol
|
1993
|
0.95
|
|
15
|
Stimulation of inflammatory markers after blunt trauma.
|
Br J Surg
|
1998
|
0.95
|
|
16
|
Identification of novel VHL targets that are associated with the development of renal cell carcinoma.
|
Oncogene
|
2006
|
0.90
|
|
17
|
Interleukin 12: a new clinical player in cytokine therapy.
|
Br J Cancer
|
1995
|
0.90
|
|
18
|
Soluble E-cadherin concentrations in patients with systemic inflammatory response syndrome and multiorgan dysfunction syndrome.
|
Br J Anaesth
|
1996
|
0.90
|
|
19
|
Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase IX and CRP in renal cell carcinoma.
|
Br J Cancer
|
2012
|
0.90
|
|
20
|
Alumina-alumina artificial hip joints. Part I: a histological analysis and characterisation of wear debris by laser capture microdissection of tissues retrieved at revision.
|
Biomaterials
|
2002
|
0.89
|
|
21
|
An evaluation of a preparation of Mycobacterium vaccae (SRL172) as an immunotherapeutic agent in renal cancer.
|
Eur J Cancer
|
2008
|
0.89
|
|
22
|
Interleukins 4 and 13 upregulate expression of cd44 in human colonic epithelial cell lines.
|
Cytokine
|
1998
|
0.88
|
|
23
|
Urinary concentrations of the soluble adhesion molecule E-cadherin and total protein in patients with bladder cancer.
|
Br J Cancer
|
1999
|
0.87
|
|
24
|
Association of serum amyloid A protein and peptide fragments with prognosis in renal cancer.
|
Br J Cancer
|
2010
|
0.84
|
|
25
|
Endotoxin, cytokines and lipid peroxides in children with intussusception.
|
Br J Surg
|
2001
|
0.83
|
|
26
|
Pre-operative urinary cathepsin D is associated with survival in patients with renal cell carcinoma.
|
Br J Cancer
|
2009
|
0.82
|
|
27
|
Phase I trial of intravesical Suramin in recurrent superficial transitional cell bladder carcinoma.
|
Br J Cancer
|
2005
|
0.82
|
|
28
|
Cytokines in combination with chemotherapy for advanced renal carcinoma--the importance of patient selection.
|
Cancer Biother Radiopharm
|
1996
|
0.81
|
|
29
|
Detection of glycosylation changes in serum and tissue proteins in cancer by lectin blotting.
|
Adv Exp Med Biol
|
2005
|
0.81
|
|
30
|
The 4th R of research.
|
Contemp Top Lab Anim Sci
|
1995
|
0.80
|
|
31
|
Urological malignancies and the proteomic-genomic interface.
|
Electrophoresis
|
1999
|
0.79
|
|
32
|
Analysis of vocal fold function in the miniswine model.
|
J Invest Surg
|
1996
|
0.78
|
|
33
|
Ameloblastic odontoma in a cynomolgus monkey (Macaca fascicularis).
|
Lab Anim Sci
|
1988
|
0.78
|
|
34
|
Plasma osteopontin concentrations in patients with cutaneous melanoma.
|
Oncol Rep
|
2013
|
0.77
|
|
35
|
Phospholipase A2 activity in serum is induced during treatment with recombinant human interleukin-6 in patients with cancer.
|
Ann Clin Biochem
|
1996
|
0.76
|
|
36
|
Ethical issues: impact of the animal rights movement on surgical research.
|
Pediatr Surg Int
|
1996
|
0.75
|
|
37
|
Polymorphonuclear elastase-alpha1-proteinase inhibitor (elastase-alpha1 antitrypsin) in patients with rheumatic diseases: influence of disease activity.
|
J Rheumatol
|
2000
|
0.75
|
|
38
|
Detection of the p35 and p40 subunits of interleukin-12 in melanoma and bladder cancer cell lines.
|
Ann N Y Acad Sci
|
1996
|
0.75
|
|
39
|
2'-Deoxyadenosine metabolism in human and opossum Didelphis virginiana erythrocytes in vitro.
|
Comp Biochem Physiol B
|
1993
|
0.75
|
|
40
|
Cytokines as tumour markers.
|
Scand J Clin Lab Invest Suppl
|
1995
|
0.75
|
|
41
|
1,2-Bis(N-fluoro-p-toluenesulfonamido)ethane chloroform solvate.
|
Acta Crystallogr C
|
2001
|
0.75
|
|
42
|
Production and characterization of monoclonal antibodies to human interleukin-12.
|
Hybridoma
|
1997
|
0.75
|
|
43
|
New Perfluorophtalate Complexes of Platinum(II) With Chemotherapeutic Potential.
|
Met Based Drugs
|
1996
|
0.75
|
|
44
|
Preparation and care of the area postrema-lesioned cat.
|
J Invest Surg
|
1989
|
0.75
|
|
45
|
The effect of enzyme replacement on red cell adenine deoxyribonucleotides in adenosine deaminase-deficient erythrocytes of the opossum, Didelphis virginiana.
|
Comp Biochem Physiol B
|
1993
|
0.75
|
|
46
|
Acute phase reactants in predicting disease outcome.
|
Baillieres Clin Rheumatol
|
1992
|
0.75
|
|
47
|
The effect of warfarin on the attachment of bone to hydroxyapatite-coated and uncoated porous implants.
|
J Bone Joint Surg Am
|
1995
|
0.75
|
|
48
|
Renal carcinoma cell lines inhibit natural killer activity via the CD94 receptor molecule.
|
Cancer Immunol Immunother
|
2001
|
0.75
|
|
49
|
Bone alkaline phosphatase in rheumatic diseases.
|
Ann Clin Biochem
|
1995
|
0.75
|
|
50
|
Modification to the RITARD surgical model.
|
J Invest Surg
|
1991
|
0.75
|